What changed in Molina Healthcare, Inc.'s latest annual report
In the year ended 31 Dec 2025, Molina Healthcare, Inc.'s revenue rose 11.7% to USD 45.43bn, from USD 40.65bn; net income fell 60% to USD 472.00m, from USD 1.18bn; long-term debt rose 28.8% to USD 3.77bn, from USD 2.92bn.
Year ended 31 Dec 2025. Source: 10-K filed 10 Feb 2026, read it on SEC EDGAR.
USD 40.65bn to USD 45.43bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 40.65bn | 45.43bn | Up 11.7% |
| Net income | 1.18bn | 472.00m | Down 60% |
| Total assets | 15.63bn | 15.56bn | Down 0.4% |
| Total liabilities | 11.13bn | 11.49bn | Up 3.2% |
| Long-term debt | 2.92bn | 3.77bn | Up 28.8% |
| Cash and cash equivalents | 4.66bn | 4.25bn | Down 8.9% |
| Shareholders' equity | 4.50bn | 4.07bn | Down 9.5% |
Questions people ask
Did Molina Healthcare, Inc.'s revenue grow last year?
Revenue grew 11.7%, from USD 40.65bn to USD 45.43bn in the year ended 31 Dec 2025.
Is Molina Healthcare, Inc. profitable?
Yes. Net income was USD 472.00m in the year ended 31 Dec 2025. The year before: USD 1.18bn.
How much cash and debt does Molina Healthcare, Inc. have?
At its latest year end (31 Dec 2025), Molina Healthcare, Inc. reported cash and cash equivalents of USD 4.25bn and long-term debt of USD 3.77bn.
Where do these numbers come from?
From Molina Healthcare, Inc.'s own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Molina Healthcare, Inc.?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demoOther Hospital & Medical Service Plans companies
- UnitedHealth Group IncorporatedNet income down 16.3%
- Elevance Health, Inc.Cash and cash equivalents up 14.5%
- The Cigna GroupNet income up 73.5%
- Humana IncCash and cash equivalents up 89.1%
- Centene CorporationCash and cash equivalents up 27.2%
- Oscar Health, Inc.Cash and cash equivalents up 81.7%